Chemomab Therapeutics Ltd. American Depositary Share (CMMB) is a publicly traded Healthcare sector company. As of September 30, 2026, CMMB trades at $1.18 with a market cap of $11.80M and a P/E ratio of 13.10. CMMB moved -26.40% today. Year to date, CMMB is -33.52%; over the trailing twelve months it is -54.75%. Its 52-week range spans $1.05 to $8.61. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces CMMB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CMMB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.18 |
| Market Cap | $11.80M |
| P/E Ratio | 13.10 |
| EPS | $0.12 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.61 |
| 52-Week Low | $1.05 |
| Volume | 659.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-27.65M |
| Gross Margin | 0.00% |
1 analysts cover CMMB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.